Spirulina.Guru

Spirulina and Macrophage Polarisation

M1 macrophages run on aerobic glycolysis and produce cytokines. M2 macrophages run on oxidative phosphorylation and resolve inflammation. Spirulina's metabolic toolkit shifts the balance.

Macrophage Polarisation: A Spectrum, Not a Binary

Macrophages are remarkably plastic innate immune cells that adopt a spectrum of activation states in response to environmental cues. The classical M1 phenotype is induced by IFN-gamma plus LPS (TLR4 ligation), producing high levels of TNF-alpha, IL-6, IL-1beta, IL-12, and IL-23, expressing iNOS to generate NO, and expressing CXCL9/10/11 to recruit Th1 cells. The alternative M2 phenotype encompasses anti-inflammatory and tissue-repair programmes driven by IL-4/IL-13 (M2a: arginase-1, YM1/CHI3L3, FIZZ1/RETNLA), IL-10 plus TGF-beta (M2c: CD206/CD163/SOCS3), and haem/IL-33 (M2d/tumour-associated macrophages). Contemporary single-cell transcriptomics reveals continuous transitional states rather than discrete poles; however, the M1/M2 conceptual framework remains useful for mechanistic analysis.

M1 Metabolism: Warburg Effect, Succinate Accumulation, HIF-1alpha

LPS/IFN-gamma-stimulated M1 macrophages undergo a rapid metabolic shift to aerobic glycolysis (the Warburg effect), increasing glucose uptake via GLUT1 (SLC2A1) upregulated by HIF-1alpha. Two TCA cycle breaks occur: (1) isocitrate dehydrogenase (IDH) is suppressed, leading to citrate accumulation that is exported to the cytoplasm for fatty acid synthesis (via ACLY) and for itaconate production (via IRG1/ACOD1, acting on cis-aconitate); (2) succinate dehydrogenase (SDH) is inhibited by itaconate and by NO-mediated Complex II S-nitrosylation, causing succinate accumulation. Excess succinate stabilises HIF-1alpha (PHD2 inhibition) driving IL-1beta expression, and generates mitochondrial ROS via reverse electron transport (Complex I RET), amplifying the inflammatory burst. This metabolic state was detailed in the succinate immunometabolism article.

M2 Metabolism: OXPHOS, FAO, and Glutamine Anaplerosis

IL-4/IL-13-polarised M2 macrophages restore oxidative phosphorylation, increasing fatty acid oxidation (FAO) driven by PPARgamma and PPARdelta/beta. IL-4 activates JAK1/3-STAT6 to induce PGC-1beta and CD36, enhancing long-chain fatty acid uptake and HADHA/HADHB mitochondrial beta-oxidation. Glutamine is used for UDP-GlcNAc synthesis (N-glycosylation of anti-inflammatory mannose receptor CD206 and dectin-1) and for succinate generation via the GABA shunt (glutamine->glutamate->alpha-KG->succinate), but unlike M1 cells, SDH remains active and succinate is fully oxidised. The resulting high OXPHOS ATP yield supports collagen crosslinking, phagocytic clearance, and sustained arginase-1 activity (converting arginine to ornithine for polyamine and proline synthesis needed for tissue repair).

AMPK: The M1-to-M2 Metabolic Switch

AMPK Thr172 phosphorylation acts as a master switch in macrophage polarisation. AMPK activation suppresses M1 responses by: (1) phosphorylating and inhibiting IKK-beta (NF-kappaB), reducing TNF-alpha, IL-6, and IL-1beta; (2) phosphorylating PFKFB3 Ser461 and ACC1 Ser79, reducing Warburg-flux NADPH and fatty acid synthesis; (3) activating SIRT1 via NAD+/NAMPT, which deacetylates NF-kappaB p65 Lys310 and HIF-1alpha Lys674, suppressing their transcriptional activity. AMPK activation promotes M2 responses by upregulating PGC-1alpha-FAO, increasing PPARgamma-Ser112 dephosphorylation (allowing full PPARgamma activity), and inducing HMOX1/HO-1 which CO-inhibits NF-kappaB. Spirulina C-phycocyanin and its metabolite phycocyanobilin activate AMPK Thr172 in macrophages at 50-100 micrograms/mL in vitro.

Nrf2-HO-1 Axis in M2 Polarisation

HO-1 (HMOX1) is a Nrf2 target gene whose expression marks the M2 anti-inflammatory phenotype. HO-1 catabolises haem to CO, biliverdin (reduced to bilirubin), and free Fe2+. CO inhibits TLR4-TRIF signalling by S-nitrosylating TLR4-associated kinases, and activates soluble guanylyl cyclase (sGC)-cGMP-PKG to phosphorylate and export NF-kappaB p65 from the nucleus. Bilirubin scavenges peroxynitrite and lipid radicals. Together these products suppress iNOS and COX-2, reduce pro-inflammatory eicosanoid production, and increase IL-10 (via PKG-mediated CREB activation). Spirulina PCB-Keap1 adduction activates Nrf2-HO-1 in macrophages, mimicking the HO-1-driven component of M2 polarisation while leaving M2a-specific STAT6 and PPARgamma programmes independent.

IL-10, STAT3, and Regulatory Macrophage Differentiation

IL-10, produced by M2c/Mreg macrophages, signals through IL-10R1/IL-10R2-JAK1/TYK2-STAT3 to induce SOCS3, which terminates JAK-STAT signalling, and to suppress LPS-induced NF-kappaB by inhibiting IKK. STAT3 also induces HMOX1 and IL-10 itself, creating an autocrine regulatory loop. C-phycocyanin increases IL-10 production in LPS-stimulated macrophages 2-3 fold at 100 micrograms/mL; this is partially dependent on HO-1-CO-cGMP-CREB-IL-10 and partially on direct NF-kappaB suppression relieving IL-12 feedback. Increased IL-10 from macrophages drives neighbouring T cells toward Treg (via STAT3-FoxP3) and Th2 (via STAT6) phenotypes, amplifying systemic anti-inflammatory polarisation.

Itaconate: Endogenous Anti-inflammatory Immunometabolite

Itaconate (produced by IRG1/ACOD1 from cis-aconitate in M1 macrophages) activates Nrf2 via Keap1 Cys288 alkylation by the cell-permeable 4-octyl itaconate (4-OI) or dimethyl itaconate (DMI) derivatives, and directly inhibits NLRP3 by succination of Cys548. These actions represent a self-limiting feedback circuit within M1 macrophages: early NF-kappaB/HIF-1alpha-driven inflammation triggers IRG1 expression, itaconate accumulates, and itaconate-Nrf2 and itaconate-NLRP3 inhibition blunt further activation. Spirulina PCB acts at the same Nrf2-Keap1 Cys288 node as itaconate and may synergise with endogenous itaconate, effectively lowering the threshold for M1 resolution.

Evidence in Chronic Inflammatory Disease Models

In murine colitis models (DSS, TNBS), spirulina supplementation shifts colonic macrophages from iNOS+/TNF-alpha+ (M1) toward arginase-1+/IL-10+ (M2) profiles assessed by flow cytometry, reducing disease activity index by 30-50%. In atherosclerotic Apoe-/- mice, spirulina reduces plaque macrophage content and shifts them toward CD163+ anti-inflammatory phenotype with decreased MMP-9 and increased TGF-beta. In obese adipose tissue macrophage models, spirulina reduces crown-like structure formation (M1 aggregates around necrotic adipocytes) and increases anti-inflammatory interstitial macrophages, correlating with improved insulin sensitivity.

Summary

Macrophage polarisation is governed by interlocking metabolic and transcriptional programmes. M1 activation requires Warburg glycolysis, succinate-HIF-1alpha, and NF-kappaB; M2 resolution requires OXPHOS, FAO, PPARgamma, and IL-10/STAT3. Spirulina engages this network at five points: AMPK activation suppressing M1 IKK-beta and Warburg flux; PCB-Nrf2-HO-1-CO opposing NF-kappaB and iNOS; Nrf2-Keap1 Cys288 synergising with endogenous itaconate anti-inflammatory feedback; IL-10 induction via HO-1-cGMP-CREB; and PGC-1alpha/FAO promotion supporting the OXPHOS-dependent M2 phenotype.

Get the weekly digest

Curated science, recipes, and brand intel — once a week, no spam, unsubscribe in one click.